Data Collection for Patients With Low Grade Ovarian or Peritoneal Tumors
2 other identifiers
observational
2,000
1 country
1
Brief Summary
This study collects information to maintain a database on patients with low-grade ovarian or peritoneal tumors. Collecting information about the type of cancer and treatment, as well as details about follow-up care, may help researchers learn and better understand these tumor types and help develop better treatments for them.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started May 2006
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 19, 2006
CompletedFirst Submitted
Initial submission to the registry
June 18, 2007
CompletedFirst Posted
Study publicly available on registry
June 20, 2007
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2034
ExpectedStudy Completion
Last participant's last visit for all outcomes
May 1, 2035
February 13, 2026
February 1, 2026
28 years
June 18, 2007
February 11, 2026
Conditions
Outcome Measures
Primary Outcomes (3)
Prospective and retrospective data collection on disease characterization, treatment, and outcomes
Up to 28 years
Organization of clinical information
Will be done in order to support multifaceted queries of patient characteristics, treatment, and disease outcome data and to facilitate correlation of these characteristics with patient outcome.
Up to 28 years
Creation of a single data repository to integrate clinical information and research findings
Up to 28 years
Secondary Outcomes (1)
Collection and storage of human tumor samples for the establishment of a tumor bank
Up to 28 years
Study Arms (1)
Observational (electronic health record review)
Patients' medical records are reviewed for retrospective and prospective data collection. Patients may also have residual tissue samples collected and stored.
Interventions
Medical records are reviewed
Patients' residual tissue samples are collected
Eligibility Criteria
Patients with a low-grade tumor of Mullerian origin who sought treatment or a second opinion at MD Anderson Cancer Center (MDACC) at any point in the course of their disease and treatment (beginning in January 1950), and patients currently being treated at MDACC or seeking treatment or a second opinion in the future
You may qualify if:
- Patients whose disease progressed to a higher-grade carcinoma since the time of original diagnosis:
- Ovarian tumor of low malignant potential
- Low-grade serous carcinoma of the ovary
- Primary peritoneal tumor of low malignant potential
- Low-grade serous carcinoma of the peritoneum
- Psammocarcinoma
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
M D Anderson Cancer Center
Houston, Texas, 77030, United States
Related Links
Biospecimen
Tissue
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
David M Gershenson
M.D. Anderson Cancer Center
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- OTHER
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 18, 2007
First Posted
June 20, 2007
Study Start
May 19, 2006
Primary Completion (Estimated)
May 1, 2034
Study Completion (Estimated)
May 1, 2035
Last Updated
February 13, 2026
Record last verified: 2026-02